PictureLake
Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis—Sionna Therapeutics (SION) priced its upsized initial public offering of ~10.59M shares at $18.00 per share.
Underwriters have a 30-day option to purchase up to ~1.588M
